Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Sells $120,650.16 in Stock

Alignment Healthcare, Inc. (NASDAQ:ALHCGet Free Report) CFO Robert Thomas Freeman sold 6,744 shares of the business’s stock in a transaction on Thursday, March 27th. The stock was sold at an average price of $17.89, for a total transaction of $120,650.16. Following the completion of the sale, the chief financial officer now owns 1,464,419 shares in the company, valued at approximately $26,198,455.91. The trade was a 0.46 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

Robert Thomas Freeman also recently made the following trade(s):

  • On Tuesday, March 18th, Robert Thomas Freeman sold 13,815 shares of Alignment Healthcare stock. The stock was sold at an average price of $16.89, for a total value of $233,335.35.
  • On Wednesday, March 12th, Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total value of $226,697.56.
  • On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total value of $3,390,121.35.
  • On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.58, for a total transaction of $3,895,000.00.

Alignment Healthcare Price Performance

ALHC opened at $18.30 on Friday. The company has a quick ratio of 1.60, a current ratio of 1.60 and a debt-to-equity ratio of 1.82. The business has a fifty day moving average of $15.28 and a 200 day moving average of $12.97. Alignment Healthcare, Inc. has a 52-week low of $4.46 and a 52-week high of $18.44. The stock has a market cap of $3.51 billion, a P/E ratio of -23.77 and a beta of 1.49.

Institutional Trading of Alignment Healthcare

Large investors have recently made changes to their positions in the stock. R Squared Ltd purchased a new position in Alignment Healthcare in the 4th quarter worth about $55,000. RiverPark Advisors LLC bought a new position in Alignment Healthcare in the 4th quarter worth about $106,000. Tower Research Capital LLC TRC increased its position in shares of Alignment Healthcare by 146.7% during the fourth quarter. Tower Research Capital LLC TRC now owns 10,571 shares of the company’s stock worth $119,000 after acquiring an additional 6,286 shares during the period. Ballentine Partners LLC bought a new stake in shares of Alignment Healthcare during the fourth quarter valued at approximately $121,000. Finally, Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Alignment Healthcare in the third quarter valued at approximately $131,000. 86.19% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ALHC has been the subject of a number of recent research reports. Piper Sandler lifted their price objective on shares of Alignment Healthcare from $14.00 to $21.00 and gave the stock an “overweight” rating in a research note on Tuesday, March 4th. Bank of America lifted their price target on Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. William Blair restated an “outperform” rating on shares of Alignment Healthcare in a research report on Friday, February 28th. JPMorgan Chase & Co. lifted their target price on Alignment Healthcare from $14.00 to $17.00 and gave the stock a “neutral” rating in a report on Thursday, March 6th. Finally, Barclays increased their price target on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, three have given a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $14.83.

Check Out Our Latest Analysis on Alignment Healthcare

About Alignment Healthcare

(Get Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Featured Articles

Insider Buying and Selling by Quarter for Alignment Healthcare (NASDAQ:ALHC)

Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.